• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经气管内滴注和气雾吸入环孢素A对幼年和成年大鼠进行肺部给药

Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats.

作者信息

Taljanski W, Pierzynowski S G, Lundin P D, Westrom B R, Eirefelt S, Podlesny J, Dahlback M, Siwinska-Golebiowska H, Karlsson B W

机构信息

Department of Immunology, National Research Institute of Mother and Child, Warsaw, Poland.

出版信息

Drug Metab Dispos. 1997 Aug;25(8):917-20.

PMID:9280398
Abstract

The delivery and pharmacokinetics of cyclosporine A (CyA) given locally to the airways or iv was evaluated in young and adult rats. After intratracheal (i.t.) instillation of saline suspended CyA to adult rats, the CyA plasma levels peaked at 30 min with a bioavailability of 78.1 +/- 6.9%. After the i.t. instillation of CyA with micelles forming surfactant, Cremophor EL, in adult and young rats, the plasma levels peaked at 5 min with a bioavailability of 77.5 +/- 7.2% and 66.3 +/- 4.5%, respectively. The bioavailability of aerosolized CyA was 80.1 +/- 4.1% in adults. Thus, CyA is absorbed by the lungs into the systemic circulation of the rat in high amounts, independent of age and type of delivery system. Long-term treatment with i.t. instillations did not affect body weight gain in young and adult rats, and no histopathological changes were found in the lungs. It is important to emphasize that CyA plasma clearance in young rats was lower and elimination half-life longer than in adults. The slow elimination of CyA in young rats indicated profound pharmacokinetic age differences for this species.

摘要

在幼年和成年大鼠中评估了局部给予气道或静脉注射环孢素A(CyA)后的给药情况及药代动力学。对成年大鼠气管内(i.t.)滴注盐水悬浮的CyA后,CyA血浆水平在30分钟时达到峰值,生物利用度为78.1±6.9%。在成年和幼年大鼠中气管内滴注含形成胶束表面活性剂聚氧乙烯蓖麻油(Cremophor EL)的CyA后,血浆水平分别在5分钟时达到峰值,生物利用度分别为77.5±7.2%和66.3±4.5%。雾化CyA在成年大鼠中的生物利用度为80.1±4.1%。因此,CyA可被大鼠肺部大量吸收进入体循环,与年龄和给药系统类型无关。长期气管内滴注治疗不影响幼年和成年大鼠的体重增加,且肺部未发现组织病理学变化。需要强调的是,幼年大鼠的CyA血浆清除率低于成年大鼠,消除半衰期长于成年大鼠。幼年大鼠中CyA的缓慢消除表明该物种存在明显的药代动力学年龄差异。

相似文献

1
Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats.经气管内滴注和气雾吸入环孢素A对幼年和成年大鼠进行肺部给药
Drug Metab Dispos. 1997 Aug;25(8):917-20.
2
[Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].[环孢素A pH敏感纳米粒的制备及其在大鼠体内的口服药代动力学]
Yao Xue Xue Bao. 2004 Dec;39(12):1023-7.
3
Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.用于口服给药的载环孢素A的pH敏感纳米颗粒的生物利用度和药代动力学
J Control Release. 2004 Jul 7;97(3):421-9. doi: 10.1016/j.jconrel.2004.03.003.
4
pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.用于提高环孢素A口服生物利用度的pH敏感纳米颗粒。
Int J Pharm. 2004 Aug 6;280(1-2):229-40. doi: 10.1016/j.ijpharm.2004.05.006.
5
Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A.聚氧乙烯蓖麻油(Cremophor EL)可释放吸附在血细胞和血管上的环孢素A,并提高环孢素A的表观血浆浓度。
Int J Pharm. 2005 Apr 11;293(1-2):137-44. doi: 10.1016/j.ijpharm.2004.12.023.
6
The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.脂蛋白水平升高对环孢素A在实验大鼠体内药代动力学的影响。
Biopharm Drug Dispos. 2006 Jan;27(1):7-16. doi: 10.1002/bdd.476.
7
Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.环孢素微乳剂(新山地明)与普通分散制剂(环孢素胶囊)在年轻健康男性志愿者中的生物利用度比较
Ther Drug Monit. 2006 Jun;28(3):312-20. doi: 10.1097/01.ftd.0000211804.89440.74.
8
[Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].[环孢素A载药羟丙基甲基纤维素邻苯二甲酸酯纳米粒在大鼠体内口服给药的相对生物利用度]
Yao Xue Xue Bao. 2004 Jun;39(6):463-6.
9
A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.一种预测基于嵌段共聚物的纳米容器体内稳定性的体外方法的新用途。
J Control Release. 2007 Sep 11;122(1):63-70. doi: 10.1016/j.jconrel.2007.06.008. Epub 2007 Jun 16.
10
Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.一种替代的载有pH敏感型环孢素A的冻干纳米颗粒制剂的制备及其在大鼠体内的药代动力学特征。
Pharmazie. 2009 Jan;64(1):26-31.

引用本文的文献

1
Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.生物制剂递送的挑战与未来前景:口腔黏膜、肺部和透皮途径
AAPS J. 2017 May;19(3):652-668. doi: 10.1208/s12248-017-0054-z. Epub 2017 Feb 13.
2
Nanoparticles for biomedical imaging: fundamentals of clinical translation.用于生物医学成像的纳米粒子:临床转化的基础。
Mol Imaging. 2010 Dec;9(6):291-310.
3
Uptake of all-trans retinoic acid-containing aerosol by inhalation to lungs in a guinea pig model system--a pilot study.豚鼠模型系统中经吸入含全反式维甲酸的气雾剂至肺部的摄取——一项初步研究。
Exp Lung Res. 2010 Dec;36(10):593-601. doi: 10.3109/01902141003790155.
4
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.纳米载体作为肺部给药系统用于治疗和诊断呼吸系统及非呼吸系统疾病。
Int J Nanomedicine. 2008;3(1):1-19.
5
The lung as a route for systemic delivery of therapeutic proteins and peptides.肺作为治疗性蛋白质和肽全身递送的途径。
Respir Res. 2001;2(4):198-209. doi: 10.1186/rr58. Epub 2001 Apr 12.